AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PRIMORUS INVESTMENTS PLC

Transaction in Own Shares Jul 15, 2025

7857_pos_2025-07-15_0cfeb68d-7627-43af-b159-0ca653a1021b.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9923Q

Primorus Investments PLC

15 July 2025

Primorus Investments plc

("Primorus" or the "Company")

Transaction in Own Shares

Primorus Investments plc (AIM: PRIM)  announces that it purchased 300,000 ordinary shares of 0.2 pence each in the capital of the Company ("Ordinary Shares") at an average price of 3.91 pence per Ordinary Share as further detailed below on 14 July 2025. All of the repurchased shares will be held in treasury.

Price (pence) Date Quantity Venue
3.91 14/07/2025 300,000 LSE

Following the above transaction, the Company will have 139,830,968 Ordinary Shares in issue and admitted to trading on AIM and will hold 1,500,000 Ordinary Shares in treasury.  The number of shares in issue (excluding treasury shares), and the figure to be used as the denominator for calculations of interests in the Company's voting rights, is 138,330,968.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information please contact:

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer
+44 (0) 20 8154 7907
Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson / James Caithie
+44 (0) 20 7213 0880

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSEZLFFEDLXBBL

Talk to a Data Expert

Have a question? We'll get back to you promptly.